Results 101 to 110 of about 13,356 (173)

A Multicentre, Prospective, Non-Interventional Single-Arm Study Investigating the Impact of Once-Daily Oral Semaglutide in a Real-World Adult Population With Type 2 Diabetes in Mexico. [PDF]

open access: yesEndocrinol Diabetes Metab
González-Gálvez G   +7 more
europepmc   +1 more source

[Cardiovascular risk in adults of indigenous descent in Argentina: an analysis of the Second National Nutrition and Health Survey] [PDF]

open access: yesRev Fac Cien Med Univ Nac Cordoba
Awruch C   +7 more
europepmc   +1 more source

Protocol for the injection of adenoviruses into brown adipose tissue in mice. [PDF]

open access: yesSTAR Protoc
Prida E   +8 more
europepmc   +1 more source

Association Between Oxidative-Inflammation Biomarkers and Incident Chronic Kidney Disease in People with High Cardiovascular Risk: A Nested Case-Control Study. [PDF]

open access: yesAntioxidants (Basel)
Quetglas-Llabrés MM   +20 more
europepmc   +1 more source

[Prevalence of Helicobacter pylori and Endoscopic and Histopathological Fin-dings in Obese Patients who are Can-didates for Bariatric Surgery]. [PDF]

open access: yesActa Gastroenterol Latinoam
Martínez Ramírez RM   +4 more
europepmc   +1 more source

Obesidade: saúde pessoal e/ ou laboral?!

open access: yesRevista Portuguesa de Saúde Ocupacional, 2016
Mónica Santos, Armando Almeida
openaire   +1 more source

La obesidad

open access: yes, 2016
La obesidad es un trastorno metabólico crónico caracterizado por la presencia de un balance energético positivo a lo largo del tiempo, que conduce a un depósito excesivo de tejido adiposo con respecto al considerado normal. La obesidad se asocia a un exceso en el número de adipocitos, a un excesivo tamaño de éstos o a ambos procesos.
openaire   +1 more source

Adherence to the Mediterranean Diet and frailty criteria in an old population with metabolic syndrome: A cross-sectional analysis. [PDF]

open access: yesJ Nutr Health Aging
Torrego-Ellacuría M   +49 more
europepmc   +1 more source

[Effectiveness of GLP-1 receptor agonists in managing patients with type 2 diabetes]. [PDF]

open access: yesAten Primaria
Bejarano Romero F   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy